Production of type 2, cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis

Arthritis and Rheumatism

Volumn 42, Issue 6, 1999, Pages 1168-1178

  Atamas, Sergei P ^a   Yurovsky, Vladimir V ^a   Wise, Robert ^b   Wigley, Fredrick M ^b   Goter Robinson, Carol J ^a   Henry, Patricia ^a   Alms, William J ^a   White, Barbara ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; COLLAGEN; COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; RANTES;

ADULT; ARTICLE; BRONCHOSCOPY; CELL CLONING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC SCLEROSIS; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; DNA PRIMERS; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-5; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY FIBROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCLERODERMA, SYSTEMIC;

EID: 0033000530     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L     Document Type: Article

References (47)

1. Medsger TA Jr, Steen VD. Classification, prognosis. In: Clements PJ, Furst DE, editors. Systemic sclerosis. Baltimore: Williams & Wilkins; 1996. p. 51-64.
2. Wallaert B, Hatron PY, Grosbois JM, Tonnel AB, Devulder B, Voisin C. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage: relationship between alveolitis and subsequent changes in lung function. Am Rev Respir Dis 1986;133:574-80.
3. Berman JS, Beer DJ, Theodore AC, Kornfeld H, Bernardo J, Center DM. Lymphocyte recruitment to the lung. Am Rev Respir Dis 1990;142:238-57.
4. Hunninghake GW, Fulmer JD, Young RC, Gadek JE, Crystal RG. Localization of the immune response in sarcoidosis. Am Rev Respir Dis 1979;120:49-57.
5. Kradin RL, Divertie MB, Colvin RB, Ramirez J, Ryu J, Carpenter HA, et al. Usual interstitial pneumonitis is a T-cell alveolitis. Clin Immunol Immunopathol 1986;40:224-35.
6. Rankin JA, Picarella DE, Ceba GP, Temann UA, Prasad B, DiCosmo B, et al. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci U S A 1996;93:7821-5.
7. Postlethewaite AE, Seyer JM. Fibroblast chemotaxis induced by human recombinant interleukin-4: identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122. J Clin Invest 1991;87:2147-52.
8. Feghali CA, Bost KL, Boulware DW, Levy LS. Human recombinant interleukin-4 induces proliferation and interleukin-6 production by cultured human skin fibroblasts. Clin Immunol Immunopathol 1992;63:182-7.
9. Postlethewaite AE, Holness MA, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 1992;90:1479-85.
10. Piela-Smith TH, Broketa G, Hand A, Korn JH. Regulation of ICAM-1 expression and function in human dermal fibroblasts by IL-4. J Immunol 1992;148:1375-81.
11. Elias JA, Jimenez SA, Freundlich B. Recombinant gamma, alpha, and beta interferon regulation of human lung fibroblast proliferation. Am Rev Respir Dis 1987;135:62-5.
12. Duncan MR, Berman B. Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 1985;162:516-27.
13. Jimenez SA, Freundlich B, Rosenbloom J. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest 1984;74:1112-6.
14. Sempowski GD, Derdak S, Phipps RP. Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblasts subsets. J Cell Physiol 1996; 167:290-6.
15. Sempowski GD, Beckmann MP, Derdak S, Phipps RP. Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors: role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J Immunol 1994;152:3606-14.
16. Needleman BW, Wigley FM, Stair RW. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor a, and interferon-γ levels in sera from patients with scleroderma. Arthritis Rheum 1992;35:67-72.
17. Kantor TV, Friberg D, Medsger TA Jr, Buckingham RB, Whiteside TL. Cytokine production and serum levels in systemic sclerosis. Clin Immunol Immunopathol 1992;65:278-85.
18. Smith EA. Connective tissue metabolism including cytokines in scleroderma. Curr Opin Rheumatol 1992;4:869-77.
19. Salmon-Ehr V, Serpier H, Nawrocki B, Gillery P, Clavel C, Kalis B, et al. Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures: potential role in fibrosis. Arch Dermatol 1996;132:802-6.
20. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1990;21:581-90.
21. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
22. White B, Bauer EA, Goldsmith LA, Hochberg MC, Katz LM, Korn JH, et al. Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. Arthritis Rheum 1995;38:351-60.
23. Merchant RK, Schwartz DA, Helmers RA, Dayton CS, Hunninghake GW. Bronchoalveolar lavage cellularity: the distribution in normal volunteers. Am Rev Respir Dis 1992;146:448-53.
24. White BN, Korn JH, Piela-Smith TH. Preferential adherence of human γ/δ, CD8+ and memory T cells to fibroblasts. J Immunol 1994;153:4912-8.
25. Atamas SP, Choi J, Yurovsky VV, White B. An alternative splice variant of human IL-4, IL-4δ2, inhibits IL-4-stimulated T cell proliferation. J Immunol 1996;156:435-41.
26. Alms W, Atamas SP, Yurovsky VV, White B. Generation of an alternative splice variant of human IL-4. Mol Immunol 1996;33: 361-70.
27. Bolster MB, Ludwicka A, Sutherland SE, Strange C, Silver RM. Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis. Arthritis Rheum 1997;40:743-51.
28. Southcott AM, Jones KP, Li D, Majumdar S, Cambrey AD, Pantelidis P, et al. Interleukin-8: differential expression in lone fibrosing alveolitis and systemic sclerosis. Am J Respir Crit Care Med 1995;151:1604-21.
29. Crestani B, Seta N, Palazzo E, Rolland C, Venembre P, Dehoux M, et al. Interleukin-8 and neutrophils in systemic sclerosis with lung involvement. Am J Respir Crit Care Med 1994;150:1363-7.
30. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991;254: 279-82.
31. Yurovsky VV, Wigley FM, Wise RA, White B. Skewing of CD8+ T cell repertoire in the lungs of patients with systemic sclerosis. Hum Immunol 1996;48:84-97.
32. Arinobu Y, Atamas SP, Otsuka T, Niiro H, Yamaoka K, Mitsuyasu H, et al. Antagonistic effect of an alternative splice variant of human IL-4, IL-4δ2, on IL-4 activities on human monocytes and B cells. Cell Immunol 1999;191:161-7.
33. White B, Moore W, Wigley FM, Xiao HQ, Wise RA. Stabilization or improvement of pulmonary function in systemic sclerosis patients with alveolitis treated with cyclophosphamide, compared to untreated patients. Submitted for publication.
34. Sad S, Marcotte R, Mosmann TR. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 1995;2:271-9.
35. Fitch FW, Stack R, Fields P, Lancki DW, Cronin DC. Regulation of T lymphocyte subsets. Ciba Found Symp 1995;195:66-80.
36. Zaronski CC, Welsh RM. Minimal bystander activation on CD8 T cells during the virus-induced polyclonal T cell response. J Exp Med 1997;185:1629-39.
37. Coyle AJ, Bertrand C, Tsuyuki S, Pircher H, Walti S, Le Gros G, et al. IL-4 differentiates naive CD8+ T cells to a "Th2-like" phenotype: a link between viral infections and bronchial asthma. Ann N Y Acad Sci 1996;758:97-103.
38. Byun DG, Demeure CE, Yang LP, Shu U, Ishihara H, Vezzio N, et al. In vitro maturation of neonatal human CD8 T lymphocytes into IL-4-and IL-5-producing cells. J Immunol 1994;153:4862-71.
39. Tsuyuki S, Tsuyuki J, Einsle K, Kopf M, Coyle AJ. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (Th2) immune response and altered airways responsiveness. J Exp Med 1997;185:1671-9.
40. Maggi E, Giudizi MG, Biagiotti R, Annunziato F, Manetti R, Piccinni MP, et al. Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med 1994;180:489-95.
41. Uyemura K, Pirmez C, Sieling PA, Kiene K, Paes-Oliveira M, Modlin RL. CD4+ type 1 and CD8+ type 2 T cell subsets in human leishmaniasis have distinct T cell receptor repertoires. J Immunol 1993;151:7095-104.
42. Li L, Sad S, Kagi D, Mosmann TR. CD8 Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions. J Immunol 1997;158:4152-61.
43. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomiaka K, et al. Interleukin-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J Immunol 1992;148: 1086-92
44. Sher A, Coffman RL, Hieny S, Scott P, Cheever AW. Interleukin-5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci U S A 1990;87:61-5.
45. Dent LA, Strath M, Mellor AL, Sanderson CJ. Eosinophilia in transgenic mice expressing interleukin-5. J Exp Med 1990;172: 1425-31.
46. Birkland TP, Cheavens MD, Pincus SH. Human eosinophils stimulate DNA synthesis and matrix production in dermal fibroblasts. Arch Dermatol Res 1994;286:312-8.
47. Chomarat P, Banchereau J. An update on interleukin-4 and its receptor. Eur Cytokine Netw 1997;8:333-44.